Enjamb (YC P26) builds full-stack AI agents for biopharma R&D that run a drug program from discovery through FDA approval. Its agents sit on top of legacy pharma systems - Benchling, Veeva, Medidata, SAS - with no migration, doing the work across clinical evidence, trial design, statistical programming, and regulatory submissions while keeping a visible source-to-submission trail. Founded in 2025 by Rayan Mubarak and Maadhav Deekshitha, the San Francisco company raised a $650K pre-seed and says its platform was used by 500+ employees at major pharma firms within weeks of launch.
MetaCell is a life-science software company staffed by scientists and software engineers who turn messy neuroscience and biology data - microscopy, MRI, EEG, electrophysiology, biologically accurate simulations - into usable, shareable, enterprise-grade online tools. Founded by the trio behind the OpenWorm project, MetaCell builds custom scientific software, cloud workspaces, and data pipelines for pharma companies and top research institutions including Johnson & Johnson, Pfizer, Biogen, Eisai, the Allen Institute, the Chan Zuckerberg Initiative, and universities like Princeton, Yale, and UCL.